Evaluation of potential immunity against the novel severe acute respiratory syndrome (SARS) coronavirus that emerged in 2019 (SARS-CoV-2) is essential for health, as well as social and economic recovery. Generation of antibody response to SARS-CoV-2 (seroconversion) may inform on acquired immunity from prior exposure, and antibodies against the SARS-CoV-2 spike protein receptor binding domain (S-RBD) are speculated to neutralize virus infection. Some serology assays rely solely on SARS-CoV-2 nucleocapsid protein (N-protein) as the antibody detection antigen; however, whether such immune responses correlate with S-RBD response and COVID-19 immunity remains unknown. Here, we generated a quantitative serological ELISA using recombinant S-RBD and N-protein for the detection of circulating antibodies in 138 serial serum samples from 30 reverse transcription PCR–confirmed, SARS-CoV-2–hospitalized patients, as well as 464 healthy and non–COVID-19 serum samples that were collected between June 2017 and June 2020. Quantitative detection of IgG antibodies against the 2 different viral proteins showed a moderate correlation. Antibodies against N-protein were detected at a rate of 3.6% in healthy and non–COVID-19 sera collected during the pandemic in 2020, whereas 1.9% of these sera were positive for S-RBD. Approximately 86% of individuals positive for S-RBD–binding antibodies exhibited neutralizing capacity, but only 74% of N-protein–positive individuals exhibited neutralizing capacity. Collectively, our studies show that detection of N-protein–binding antibodies does not always correlate with presence of S-RBD–neutralizing antibodies and caution against the extensive use of N-protein–based serology testing for determination of potential COVID-19 immunity.
Kathleen M. McAndrews, Dara P. Dowlatshahi, Jianli Dai, Lisa M. Becker, Janine Hensel, Laura M. Snowden, Jennifer M. Leveille, Michael R. Brunner, Kylie W. Holden, Nikolas S. Hopkins, Alexandria M. Harris, Jerusha Kumpati, Michael A. Whitt, J. Jack Lee, Luis L. Ostrosky-Zeichner, Ramesha Papanna, Valerie S. LeBleu, James P. Allison, Raghu Kalluri
Title and authors | Publication | Year |
---|---|---|
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data
Claus J, ten Doesschate T, Taks E, Debisarun PA, Smits G, van Binnendijk R, van der Klis F, Verhagen LM, de Jonge MI, Bonten MJ, Netea MG, van de Wijgert JH |
Human vaccines | 2024 |
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
Leekha A, Saeedi A, Sefat KM, Kumar M, Martinez-Paniagua M, Damian A, Kulkarni R, Reichel K, Rezvan A, Masoumi S, Liu X, Cooper LJ, Sebastian M, Sands CM, Das VE, Patel NB, Hurst B, Varadarajan N |
Nature Communications | 2024 |
Vascular heterogeneity of tight junction Claudins guides organotropic metastasis.
Zhou X, LeBleu VS, Fletcher-Sananikone E, Kim J, Dai J, Li B, Wu CC, Sugimoto H, Miyake T, Becker LM, Volpert OV, Lawson E, Espinosa Da Silva C, Patel SI, Kizu A, Ehsanipour EA, Sha D, Karam JA, McAndrews KM, Kalluri R |
Nature cancer | 2024 |
Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada
Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin MÈ, Cheriet I, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C |
International Journal of Infectious Diseases | 2023 |
Waning anti-SARS-CoV-2 receptor-binding domain total antibody in CoronaVac-vaccinated individuals in Indonesia
Harapan H, Ar Royan H, Tyas II, Nadira A, Abdi IF, Anwar S, Husnah M, Ichsan I, Pranata A, Mudatsir M, Syukri M, Rizal S, . R, . H, Kurniawan R, Irwansyah I, Sofyan SE |
F1000Research | 2023 |
Waning anti-SARS-CoV-2 receptor-binding domain total antibody in CoronaVac-vaccinated individuals in Indonesia.
Harapan H, Ar Royan H, Tyas II, Nadira A, Abdi IF, Anwar S, Husnah M, Ichsan I, Pranata A, Mudatsir M, Syukri M, Rizal S, Razali, Hamdani, Kurniawan R, Irwansyah I, Sofyan SE |
F1000Research | 2023 |
A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge
Xia M, López K, Vago FS, Huang P, Auguste DI, Jiang W, Auguste AJ, Tan M |
Biotechnology Journal | 2023 |
Optimizing SARS-CoV-2 Immunoassays for Specificity in Dengue-Co-Endemic Areas.
Adnan N, Haq MA, Tisha TA, Khandker SS, Jamiruddin MR, Sajal SSA, Akter S, Ahmed MF, Raqib R, Khondoker MU, Azmuda N, Haque M |
Cureus | 2023 |
RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity
Angioni R, Bonfanti M, Caporale N, Sánchez-Rodríguez R, Munari F, Savino A, Pasqualato S, Buratto D, Pagani I, Bertoldi N, Zanon C, Ferrari P, Ricciardelli E, Putaggio C, Ghezzi S, Elli F, Rotta L, Scardua A, Weber J, Cecatiello V, Iorio F, Zonta F, Cattelan AM, Vicenzi E, Vannini A, Molon B, Villa CE, Viola A, Testa G |
Cell reports. Medicine | 2023 |
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke, KH Liang, TY Hsieh, HC Wu |
Journal of Biomedical Science | 2022 |
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
A Cristiano, M Pieri, S Sarubbi, M Pelagalli, G Calugi, F Tomassetti, S Bernardini, M Nuccetelli |
Clinical Immunology | 2022 |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
K Hoschler, S Ijaz, N Andrews, S Ho, S Dicks, K Jegatheesan, J Poh, L Warrener, T Kankeyan, F Baawuah, J Beckmann, I Okike, S Ahmad, J Garstang, A Brent, B Brent, F Aiano, K Brown, M Ramsay, D Brown, J Parry, S Ladhani, M Zambon, K Shier |
Microbiology spectrum | 2022 |
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
S Ajmeriya, A Kumar, S Karmakar, S Rana, H Singh |
JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE | 2022 |
Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients
S Jugwanth, M Gededzha, N Mampeule, N Zwane, A David, W Burgers, J Blackburn, J Grove, J George, I Sanne, L Scott, W Stevens, E Mayne, H Wu |
PloS one | 2022 |
Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations
C Hu, D Li, Z Liu, L Ren, J Su, M Zhu, Y Feng, Z Wang, Q Liu, B Zhu, Y Shao |
Pathogens | 2022 |
Low-entry-barrier point-of-care testing of anti-SARS-CoV-2 IgG in the population of Upper Austria from December 2020 until April 2021—a feasible surveillance strategy for post-pandemic monitoring?
C Doppler, M Feischl, C Ganhör, S Puh, M Müller, M Kotnik, T Mimler, M Sonnleitner, D Bernhard, C Wechselberger |
Analytical and Bioanalytical Chemistry | 2022 |
The (apparent) antibody paradox in COVID-19
R Ameratunga, S Woon, E Lea, R Steele, K Lehnert, E Leung, A Brooks |
Expert Review of Clinical Immunology | 2022 |
Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose
B Biedunkiewicz, L Tylicki, W Ślizień, M Lichodziejewska-Niemierko, M Dąbrowska, A Kubanek, S Rodak, K Polewska, P Tylicki, M Renke, A Dębska-Ślizień |
Human vaccines | 2022 |
Efficacy of antibody response following the vaccination of SARS‐CoV‐2 infected and noninfected healthcare workers by two‐dose inactive vaccine against COVID‐19
Dundar B, Karahangil K, Elgormus CS, Topsakal HN |
Journal of Medical Virology | 2022 |
N protein‐based ultrasensitive SARS‐CoV‐2 antibody detection in seconds via 3D nanoprinted, microarchitected array electrodes
Ali MA, Hu C, Zhang F, Jahan S, Yuan B, Saleh MS, Gao S, Panat R |
Journal of Medical Virology | 2022 |
On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
Fernandes-Siqueira LO, Ferreira FA, Sousa BG, Mebus-Antunes NC, Neves-Martins TC, Almeida FC, Ferreira GC, Salmon D, Wermelinger LS, Da Poian AT |
Scientific Reports | 2022 |
Human IgG antibody responses to severe acute respiratory syndrome coronavirus 2 viral antigens receptor-binding domain, spike, and nucleocapsid, in vaccinated adults from Merida, Mexico.
Puerta-Guardo H, Parra-Cardeña M, Peña-Miranda F, Flores-Quintal F, Granja-Pérez P, Villanueva-Jorge S, González-Losa R, Conde-Ferraez L, Gómez-Carballo J, Vazquez-Prokopec G, Earnest JT, Manrique-Saide P, Ayora-Talavera G |
Frontiers in Medicine | 2022 |
Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees.
Younes N, Al-Sadeq DW, Shurrab FM, Zedan HT, Abou-Saleh H, Abo-Halawa BY, AlHamaydeh FM, Elsharafi AE, Daas HI, Thomas S, Aboalmaaly S, Al Farsi A, Al-Buainain R, Ataelmannan S, Paul J, Al Saadi AS, Yassine HM, Majdalawieh AF, Ismail A, Abu-Raddad LJ, Nasrallah GK |
Human vaccines | 2022 |
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
Rak A, Donina S, Zabrodskaya Y, Rudenko L, Isakova-Sivak I |
Viruses | 2022 |
Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months
Lea CS, Simeonsson K, Kipp AM, McNeill C, Wilcox L, Irish W, Morris H, Diaz OM, Fallon JT, Roper RL |
Human vaccines | 2022 |
Colorimetric and Raman dual-mode lateral flow immunoassay detection of SARS-CoV-2 N protein antibody based on Ag nanoparticles with ultrathin Au shell assembled onto Fe(3)O(4) nanoparticles.
Li J, Liang P, Zhao T, Guo G, Zhu J, Wen C, Zeng J |
Analytical and Bioanalytical Chemistry | 2022 |
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
Pons S, Uhel F, Frapy E, Sérémé Y, Zafrani L, Aschard H, Skurnik D |
Stem Cell Reviews and Reports | 2022 |
Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.
Kim J, Kim D, Baek K, Kim M, Kang BM, Maharjan S, Park S, Choi JK, Kim S, Kim YK, Park MS, Lee Y, Kwon HJ |
Viruses | 2022 |
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, Victoria L. Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross, Janie Liang, Elena Postnikova, Steven Mazur, Vladimir V. Lukin, Anu Chaudhary, Marie K. Das, Susan L. Fink, Andrew Bryan, Alexander L. Greninger, Keith R. Jerome, Michael R. Holbrook, Terry B. Gernsheimer, Mark H. Wener, Anna Wald, David M. Koelle |
Journal of Clinical Investigation | 2021 |
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois |
EBioMedicine | 2021 |
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, D Jonigk, R Chocron, GB Pier, N Gendron, S Pons, JL Diehl, C Margadant, C Guerin, EJ Huijbers, A Philippe, N Chapuis, P Nowak-Sliwinska, C Karagiannidis, O Sanchez, P Kümpers, D Skurnik, AM Randi, AW Griffioen |
Angiogenesis | 2021 |
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
S Kang, M Yang, S He, Y Wang, X Chen, YQ Chen, Z Hong, J Liu, G Jiang, Q Chen, Z Zhou, Z Zhou, Z Huang, , H He, W Zheng, HX Liao, F Xiao, H Shan, S Chen |
Nature Communications | 2021 |
Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
S Sanaie, E Golipour, A Shamekh, MR Sadaie, A Mahmoodpoor, M Yousefi |
International Immunopharmacology | 2021 |
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
T Schwarz, K Heiss, Y Mahendran, F Casilag, F Kurth, LE Sander, CM Wendtner, MA Hoechstetter, MA Müller, R Sekul, C Drosten, V Stadler, VM Corman |
Frontiers in immunology | 2021 |
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
KA Eberhardt, F Dewald, E Heger, L Gieselmann, K Vanshylla, M Wirtz, F Kleipass, W Johannis, P Schommers, H Gruell, KA Brensing, RU Müller, M Augustin, C Lehmann, M Koch, F Klein, VD Cristanziano |
Microorganisms | 2021 |
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
M Dileepan, D Di, Q Huang, S Ahmed, D Heinrich, H Ly, Y Liang |
Virulence | 2021 |
Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area
S Jain, K Garg, SM Tran, IL Rask, M Tarczon, V Nandi, DA Kessler, D Strauss, BS Sachais, K Yazdanbakhsh, S Rehmani, L Luchsinger, PA Shi |
Transfusion | 2021 |
Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2
A Marchand, I Roulland, F Semence, O Beck, M Ericsson |
Life Sciences | 2021 |
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
MV Murhekar, T Bhatnagar, JW Thangaraj, V Saravanakumar, MS Kumar, S Selvaraju, K Rade, CP Kumar, R Sabarinathan, A Turuk, S Asthana, R Balachandar, SD Bangar, AK Bansal, V Chopra, D Das, AK Deb, KR Devi, V Dhikav, GR Dwivedi, SM Khan, MS Kumar, A Laxmaiah, M Madhukar, A Mahapatra, C Rangaraju, J Turuk, R Yadav, R Andhalkar, K Arunraj, DK Bharadwaj, P Bharti, D Bhattacharya, J Bhat, AS Chahal, D Chakraborty, A Chaudhury, H Deval, S Dhatrak, R Dayal, D Elantamilan, P Giridharan, I Haq, RK Hudda, B Jagjeevan, A Kalliath, S Kanungo, NN Krishnan, JS Kshatri, A Kumar, N Kumar, VG Kumar, GG Lakshmi, G Mehta, NK Mishra, A Mitra, K Nagbhushanam, A Nimmathota, AR Nirmala, AK Pandey, GV Prasad, MA Qurieshi, SD Reddy, A Robinson, S Sahay, R Saxena, K Sekar, VK Shukla, HB Singh, PK Singh, P Singh, R Singh, N Srinivasan, DS Varma, A Viramgami, VC Wilson, S Yadav, S Yadav, K Zaman, A Chakrabarti, A Das, RS Dhaliwal, S Dutta, R Kant, AM Khan, K Narain, S Narasimhaiah, C Padmapriyadarshini, K Pandey, S Pati, S Patil, H Rajkumar, T Ramarao, YK Sharma, S Singh, S Panda, DC Reddy, B Bhargava, T Anand, GR Babu, H Chauhan, T Dikid, RR Gangakhedkar, S Kant, S Kulkarni, JP Muliyil, RM Pandey, S Sarkar, N Shah, A Shrivastava, SK Singh, S Zodpe, A Hindupur, PR Asish, M Chellakumar, D Chokkalingam, S Dasgupta, MM Gowtham, A Jose, K Kalaiyarasi, NN Karthik, T Karunakaran, G Kiruthika, HD Kumar, SS Kumar, MP Kumar, E Michaelraj, J Pradhan, EB Prasath, DG Rachel, S Rani, A Rozario, R Sivakumar, PG Soundari, K Sujeetha, A Vinod |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
V Legros, S Denolly, M Vogrig, B Boson, E Siret, J Rigaill, S Pillet, F Grattard, S Gonzalo, P Verhoeven, O Allatif, P Berthelot, C Pélissier, G Thiery, E Botelho-Nevers, G Millet, J Morel, S Paul, T Walzer, FL Cosset, T Bourlet, B Pozzetto |
Cellular and Molecular Immunology | 2021 |
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro
J Lyu, L Bao, X Shen, C Yan, C Zhang, W Wei, Y Yang, J Li, J Dong, L Xiao, X Zhou, Y Li |
International Immunopharmacology | 2021 |
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
J Castillo-Olivares, DA Wells, M Ferrari, AC Chan, P Smith, A Nadesalingam, M Paloniemi, GW Carnell, L Ohlendorf, D Cantoni, M Mayora-Neto, P Palmer, P Tonks, NJ Temperton, D Peterhoff, P Neckermann, R Wagner, R Doffinger, S Kempster, AD Otter, A Semper, T Brooks, A Albecka, LC James, M Page, W Schwaeble, H Baxendale, JL Heeney |
Frontiers in immunology | 2021 |
An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
N Wohlgemuth, K Whitt, S Cherry, EK Roubidoux, CY Lin, KJ Allison, A Gowen, P Freiden, EK Allen, AH Gaur, JH Estepp, L Tang, T Mori, DR Hijano, H Hakim, MA McGargill, F Krammer, MA Whitt, J Wolf, PG Thomas, S Schultz-Cherry, DR Perez |
Microbiology spectrum | 2021 |
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
D Camerini, AZ Randall, K Trappl-Kimmons, A Oberai, C Hung, J Edgar, A Shandling, V Huynh, AA Teng, G Hermanson, JV Pablo, MM Stumpf, SN Lester, J Harcourt, A Tamin, M Rasheed, NJ Thornburg, PS Satheshkumar, X Liang, RB Kennedy, A Yee, M Townsend, JJ Campo, A Sinclair |
Microbiology spectrum | 2021 |
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
T Molnar, R Varnai, D Schranz, L Zavori, Z Peterfi, D Sipos, M Tőkés-Füzesi, Z Illes, A Buki, P Csecsei |
Journal of Clinical Medicine | 2021 |
Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
G Ireland, A Jeffery-Smith, M Zambon, K Hoschler, R Harris, J Poh, F Baawuah, J Beckmann, IO Okike, S Ahmad, J Garstang, AJ Brent, B Brent, F Aiano, Z Amin-Chowdhury, L Letley, SE Jones, M Kall, M Patel, R Gopal, R Borrow, E Linley, G Amirthalingam, KE Brown, ME Ramsay, SN Ladhani |
2021 | |
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
HN Grome, M Threlkeld, S Threlkeld, C Newman, RB Martines, S Reagan-Steiner, MA Whitt, M Gomes-Solecki, N Nair, MM Fill, TF Jones, W Schaffner, J Dunn |
Emerging infectious diseases | 2021 |
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
J Fröberg, J Gillard, R Philipsen, K Lanke, J Rust, D van Tuijl, K Teelen, T Bousema, E Simonetti, CE van der Gaast-de Jongh, M Bos, FJ van Kuppeveld, BJ Bosch, M Nabuurs-Franssen, N van der Geest-Blankert, C van Daal, MA Huynen, MI de Jonge, DA Diavatopoulos |
Nature Communications | 2021 |
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Y Wang, R Chen, F Hu, Y Lan, Z Yang, C Zhan, J Shi, X Deng, M Jiang, S Zhong, B Liao, K Deng, J Tang, L Guo, M Jiang, Q Fan, M Li, J Liu, Y Shi, X Deng, X Xiao, M Kang, Y Li, W Guan, Y Li, S Li, F Li, N Zhong, X Tang |
2021 | |
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
NY Pang, AS Pang, VT Chow, DY Wang |
Military Medical Research | 2021 |
SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
AY Popova, VS Smirnov, EE Andreeva, EA Babura, SV Balakhonov, NS Bashketova, SA Bugorkova, MV Bulanov, NN Valeullina, VV Vetrov, DV Goryaev, TN Detkovskaya, EB Ezhlova, NN Zaitseva, OA Istorik, IV Kovalchuk, DN Kozlovskikh, SY Kombarova, OP Kurganova, AE Lomovtsev, LA Lukicheva, LV Lyalina, AA Melnikova, OM Mikailova, AK Noskov, LN Noskova, EE Oglezneva, TP Osmolovskaya, MA Patyashina, NA Penkovskaya, LV Samoilova, TF Stepanova, OE Trotsenko, AA Totolian |
Viruses | 2021 |
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
J Favresse, C Gillot, LD Chiaro, C Eucher, M Elsen, SV Eeckhoudt, C David, L Morimont, JM Dogné, J Douxfils |
Viruses | 2021 |
Enhancing the Stability of COVID‐19 Serological Assay through Metal–Organic Framework Encapsulation
Y Wang, Z Wang, P Gupta, JJ Morrissey, RR Naik, S Singamaneni |
Advanced Healthcare Materials | 2021 |
SARS‐CoV‐2 antibodies started to decline just four months after COVID‐19 infection in a paediatric population
A Breuer, A Raphael, H Stern, M Odeh, J Fiszlinski, N Algur, S Magen, O Megged, Y Schlesinger, Y BarakCorren, E Heiman |
Acta paediatrica (Oslo, Norway : 1992) | 2021 |
Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
SF Brynjolfsson, H Sigurgrimsdottir, ED Einarsdottir, GA Bjornsdottir, B Armannsdottir, GE Baldvinsdottir, A Bjarnason, O Gudlaugsson, S Gudmundsson, ST Sigurdardottir, A Love, KG Kristinsson, BR Ludviksson |
Frontiers in immunology | 2021 |
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test
JT Heggestad, DS Kinnamon, LB Olson, J Liu, G Kelly, SA Wall, S Oshabaheebwa, Z Quinn, CM Fontes, DY Joh, AM Hucknall, C Pieper, JG Anderson, IA Naqvi, L Chen, LG Que, T Oguin, SK Nair, BA Sullenger, CW Woods, TW Burke, GD Sempowski, BD Kraft, A Chilkoti |
Science Advances | 2021 |
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
A Deshpande, BD Harris, L Martinez-Sobrido, JJ Kobie, MR Walter |
Frontiers in immunology | 2021 |
Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
T Perkmann, T Koller, N Perkmann-Nagele, M Klausberger, M Duerkop, B Holzer, B Hartmann, P Mucher, A Radakovics, M Ozsvar-Kozma, OF Wagner, CJ Binder, H Haslacher, W Lainhart |
Microbiology spectrum | 2021 |
The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
J Kulikowska, A Kulczyńska-Przybik, B Mroczko, A Kułakowska |
International journal of molecular sciences | 2021 |
Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods
P Emmerich, R Possel, CJ Hemmer, C Fritzsche, H GeerdesFenge, B Menge, C Messing, V BorchardtLohölter, C Deschermeier, K Steinhagen |
Journal of Medical Virology | 2021 |
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
D Alfego, A Sullivan, B Poirier, J Williams, A Grover, L Gillim, D Adcock, S Letovsky |
2021 | |
Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia
C Cucunawangsih, RS Wijaya, NP Lugito, I Suriapranata |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings
DO Andrey, S Yerly, B Meyer, I Arm-Vernez, P Roux-Lombard, G Togni, I Guessous, H Spechbach, S Stringhini, T Agoritsas, J Stirnemann, JL Reny, CA Siegrist, I Eckerle, L Kaiser, N Vuilleumier |
Journal of Clinical Medicine | 2021 |
Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors
Z Szabó, T Szabó, K Bodó, G Kemenesi, F Földes, K Kristóf, E Barabás, B Vásárhelyi, Z Prohászka, E Fodor, F Jakab, T Berki, Z Lacza |
Practical Laboratory Medicine | 2021 |
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
M Hiki, Y Tabe, T Ai, Y Matsue, N Harada, K Sugimoto, Y Matsushita, M Matsushita, M Wakita, S Misawa, M Idei, T Miida, N Tamura, K Takahashi, T Naito, C Selvaraj |
PloS one | 2021 |
Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region
O Nyabi, M Bentahir, J Ambroise, B Bearzatto, N Chibani, B Smits, JF Durant, A Vybornov, O Thellin, BE Moualij, JL Gala |
International journal of environmental research and public health | 2021 |
Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
A Dörschug, H Frickmann, J Schwanbeck, E Yilmaz, K Mese, A Hahn, U Groß, AE Zautner |
Diagnostics | 2021 |
Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA
JS Schultz, MK McCarthy, C Rester, KR Sabourin, K Annen, M DomBourian, E Eisenmesser, A Frazer-Abel, V Knight, T Jaenisch, TE Morrison, R Rochford, RM Kedl, YW Tang |
Journal of clinical microbiology | 2021 |
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
X Feng, J Yin, J Zhang, Y Hu, Y Ouyang, S Qiao, H Zhao, T Zhang, X Li, L Zhang, J Zhang, R Jin, Y Feng, B Su |
Frontiers in immunology | 2021 |
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
P van Dam, M Huizing, E Roelant, A Hotterbeekx, FH Winter, S Kumar-Singh, P Moons, Z Amajoud, C Vulsteke, L Croes, A Janssens, Z Berneman, H Prenen, L Meuris, WV Berghe, E Smits, M Peeters |
European Journal of Cancer | 2021 |
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali
J Woodford, I Sagara, A Dicko, A Zeguime, MB Doucoure, J Kwan, I Zaidi, J Doritchamou, M Snow-Smith, N Alani, J Renn, I Kosik, J Holly, J Yewdell, D Esposito, K Sadtler, P Duffy |
The Journal of Infectious Diseases | 2021 |
In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses
A Castro, K Ozturk, M Zanetti, H Carter, J Bhattacharya |
PloS one | 2021 |
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
JM Capcha, G Lambert, DM Dykxhoorn, AG Salerno, JM Hare, MA Whitt, S Pahwa, DT Jayaweera, LA Shehadeh |
Frontiers in Cardiovascular Medicine | 2021 |
The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
Y Fu, Y Pan, Z Li, Y Li |
Frontiers in microbiology | 2021 |
Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
N Renard, S Daniel, N Cayet, M Pecquet, F Raymond, S Pons, J Lupo, C Tourneur, C Pretis, G Gerez, P Blasco, M Combe, I Canova, M Lesénéchal, F Berthier, YW Tang |
Journal of clinical microbiology | 2021 |
The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
CE dos Santos Ferreira, H Gómez-Dantés, NC Bellei, E López, KA Crespo, M ORyan, J Villegas |
Viruses | 2021 |
Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples
A Szymczak, N Jędruchniewicz, A Torelli, A Kaczmarzyk-Radka, R Coluccio, M Kłak, A Konieczny, S Ferenc, W Witkiewicz, E Montomoli, P Miernikiewicz, R Bąchor, K Dąbrowska |
Journal of General Virology | 2021 |
Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina
B Šušak, V Mikulić, A Lazarević, I Mikulić, J Arapovic |
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences | 2021 |
Expression of SARS-CoV-2 surface glycoprotein fragment 319–640 in E. coli, and its refolding and purification
Fitzgerald GA, Komarov A, Kaznadzey A, Mazo I, Kireeva ML |
Protein Expression and Purification | 2021 |
Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications
Sun Z, Zheng X, Ji F, Zhou M, Su X, Ren K, Li L |
2021 | |
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali.
Sagara I, Woodford J, Dicko A, Zeguime A, Doucoure M, Kwan J, Zaidi I, Doritchamou J, Snow-Smith M, Alani N, Renn J, Kosik I, Holly J, Yewdell J, Esposito D, Sadtler K, Duffy P |
medRxiv : the preprint server for health sciences | 2021 |
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
KM Sohn, SG Lee, HJ Kim, S Cheon, H Jeong, J Lee, IS Kim, P Silwal, YJ Kim, S Paik, C Chung, C Park, YS Kim, EK Jo |
Journal of Korean Medical Science | 2020 |
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies
VP Waman, N Sen, M Varadi, A Daina, SJ Wodak, V Zoete, S Velankar, C Orengo |
Briefings in Bioinformatics | 2020 |
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
N Cimolai |
2020 | |
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
K Oved, L Olmer, Y Shemer-Avni, T Wolf, L Supino-Rosin, G Prajgrod, Y Shenhar, I Payorsky, Y Cohen, Y Kohn, V Indenbaum, R Lazar, V Geylis, MT Oikawa, E Shinar, E Stoyanov, L Keinan-Boker, R Bassal, S Reicher, R Yishai, A Bar-Chaim, R Doolman, Y Reiter, E Mendelson, Z Livneh, LS Freedman, Y Lustig |
2020 | |
An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens
C Gillot, J Douxfils, J Cadrobbi, K Laffineur, JM Dogné, M Elsen, C Eucher, S Melchionda, É Modaffarri, M Tré-Hardy, J Favresse |
Journal of Clinical Medicine | 2020 |
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, E Teng, M Kamruzzaman, WF Garcia-Beltran, M Astudillo, D Yang, TE Miller, E Oliver, S Fischinger, C Atyeo, AJ Iafrate, SB Calderwood, SA Lauer, J Yu, Z Li, J Feldman, BM Hauser, TM Caradonna, JA Branda, SE Turbett, RC LaRocque, G Mellon, DH Barouch, AG Schmidt, AS Azman, G Alter, ET Ryan, JB Harris, RC Charles |
Science Immunology | 2020 |
Multiplexed, quantitative serological profiling of COVID-19 from a drop of blood by a point-of-care test.
Heggestad JT, Kinnamon DS, Olson LB, Liu J, Kelly G, Wall SA, Fontes CM, Joh DY, Hucknall AM, Pieper C, Naqvi IA, Chen L, Que LG, Oguin T 3rd, Nair SK, Sullenger BA, Woods CW, Sempowski GD, Kraft BD, Chilkoti A |
medRxiv : the preprint server for health sciences | 2020 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |